Dipna Pharmachem Limited (BOM:543594)
India · Delayed Price · Currency is INR 5.44
-0.15 (-2.68%)
At close: Jul 15, 2026
Dipna Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,291 | 1,249 | 1,643 | 999.27 | 727.55 |
| 1,291 | 1,249 | 1,643 | 999.27 | 727.55 | |
Revenue Growth (YoY) | 3.33% | -23.99% | 64.46% | 37.35% | 134.70% |
Cost of Revenue | 1,075 | 1,137 | 1,579 | 954.95 | 686.13 |
Gross Profit | 215.57 | 111.71 | 64 | 44.33 | 41.42 |
Selling, General & Admin | 4.11 | 4.53 | 5.14 | 0.81 | 0.7 |
Other Operating Expenses | 161.49 | 69.8 | 24.41 | 20 | 18.97 |
Operating Expenses | 165.75 | 74.44 | 29.73 | 20.92 | 19.73 |
Operating Income | 49.83 | 37.27 | 34.27 | 23.41 | 21.7 |
Interest Expense | -14.63 | -23.2 | -20.12 | -9.66 | -6.06 |
Interest & Investment Income | - | 0.13 | 0.03 | 0.06 | 0.09 |
Other Non Operating Income (Expenses) | 0.25 | 0 | 0.02 | 0 | 0.02 |
Pretax Income | 35.45 | 14.2 | 14.19 | 13.81 | 15.74 |
Income Tax Expense | 9.13 | 4.46 | 3.34 | 4.69 | 4.07 |
Net Income | 26.32 | 9.74 | 10.85 | 9.12 | 11.67 |
Net Income to Common | 26.32 | 9.74 | 10.85 | 9.12 | 11.67 |
Net Income Growth | 170.19% | -10.25% | 19.02% | -21.85% | 4721.77% |
Shares Outstanding (Basic) | 26 | 24 | 12 | 12 | 0 |
Shares Outstanding (Diluted) | 26 | 24 | 12 | 12 | 0 |
Shares Change (YoY) | 10.78% | 97.02% | 0.50% | 7042.07% | - |
EPS (Basic) | 1.00 | 0.41 | 0.90 | 0.76 | 69.46 |
EPS (Diluted) | 1.00 | 0.41 | 0.90 | 0.76 | 69.46 |
EPS Growth | 143.90% | -54.44% | 18.42% | -98.91% | 4721.77% |
Free Cash Flow | -183.63 | -92.15 | -54.31 | -209.86 | 27.99 |
Free Cash Flow Per Share | -6.98 | -3.88 | -4.50 | -17.49 | 166.59 |
Gross Margin | 16.70% | 8.94% | 3.89% | 4.44% | 5.69% |
Operating Margin | 3.86% | 2.98% | 2.09% | 2.34% | 2.98% |
Profit Margin | 2.04% | 0.78% | 0.66% | 0.91% | 1.60% |
Free Cash Flow Margin | -14.23% | -7.38% | -3.31% | -21.00% | 3.85% |
EBITDA | 49.97 | 37.39 | 34.44 | 23.52 | 21.76 |
EBITDA Margin | 3.87% | 2.99% | 2.10% | 2.35% | 2.99% |
D&A For EBITDA | 0.14 | 0.11 | 0.17 | 0.12 | 0.06 |
EBIT | 49.83 | 37.27 | 34.27 | 23.41 | 21.7 |
EBIT Margin | 3.86% | 2.98% | 2.09% | 2.34% | 2.98% |
Effective Tax Rate | 25.75% | 31.40% | 23.54% | 33.98% | 25.88% |
Revenue as Reported | 1,291 | 1,249 | 1,643 | 999.34 | 727.66 |
Advertising Expenses | - | 0.07 | 0.13 | 0.04 | - |